Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.01
(
1.02%
)
US TECH 100
26,720.00
(
0.97%
)
Dow Jones
49,652.14
(
1.62%
)
Brent Oil
111.10
(
-1.13%
)
Bitcoin
76,479.26
(
0.93%
)
News Focus
News Focus
Post# of 30520
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122916
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 25727

Wednesday, 04/20/2022 10:45:34 AM

Wednesday, April 20, 2022 10:45:34 AM

Post# of 30520
ABT sold $3.3B of COVID diagnostics in 1Q22:

https://abbott.mediaroom.com/2022-04-20-Abbott-Reports-First-Quarter-2022-Results

Full-year 2022 non-GAAP EPS guidance remains unchanged at $4.70+. This guidance includes only $1.2B of cumulative COVID-diagnostics sales for 2Q22/3Q22/4Q22, which seems like a conservative forecast.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today